CAPTRUST Financial Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
27,149
+15,591
+135% +$150K ﹤0.01% 2352
2026
Q1
$85.7K Buy
11,558
+274
+2% +$2.88K ﹤0.01% 2831
2025
Q4
$133K Buy
+11,284
New +$122K ﹤0.01% 2583
2025
Q3
Sell
-10,299
Closed -$75.3K 2679
2025
Q2
$75.3K Buy
+10,299
New +$83.1K ﹤0.01% 2396
2024
Q1
Sell
-55,451
Closed -$897K 2469
2023
Q4
$897K Sell
55,451
-29,049
-34% -$475K ﹤0.01% 1335
2023
Q3
$1.04M Buy
84,500
+10,320
+14% +$153K ﹤0.01% 1187
2023
Q2
$1.19M Buy
+74,180
New +$1.22M ﹤0.01% 1104
2022
Q3
Sell
-5,650
Closed -$46K 3308
2022
Q2
$46K Buy
5,650
+714
+14% +$6.82K ﹤0.01% 2818
2022
Q1
$60K Buy
4,936
+3,958
+405% +$83.3K ﹤0.01% 2662
2021
Q4
$33K Buy
978
+159
+19% +$6.23K ﹤0.01% 2963
2021
Q3
$40K Buy
819
+32
+4% +$1.48K ﹤0.01% 2729
2021
Q2
$36K Sell
787
-538
-41% -$23.8K ﹤0.01% 2720
2021
Q1
$64K Buy
1,325
+1,110
+516% +$57.8K ﹤0.01% 2260
2020
Q4
$12K Buy
215
+25
+13% +$1.13K ﹤0.01% 2487
2020
Q3
$7K Buy
+190
New +$7.06K ﹤0.01% 2429
2019
Q4
Sell
-3,000
Closed -$57K 1508
2019
Q3
$57K Hold
3,000
﹤0.01% 953
2019
Q2
$66K Buy
+3,000
New +$65.8K ﹤0.01% 886

Other funds holding NEO

CAPTRUST Financial Advisors's NEO Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its NeoGenomics (NEO) stake by 135% in Q2 2026, buying an estimated $150K and bringing the position to 27,149 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

CAPTRUST Financial Advisors first reported a position in NEO in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.19M in Q2 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • CAPTRUST Financial Advisors held 27,149 shares of NeoGenomics worth $396K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 15,591 NeoGenomics shares in Q2 2026, an estimated $150K.
  • NeoGenomics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2352 holding.
  • CAPTRUST Financial Advisors first reported a position in NeoGenomics in Q2 2019 and has held it in 17 quarters since.
  • CAPTRUST Financial Advisors's NeoGenomics position peaked at $1.19M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.